{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:13:03Z","timestamp":1792591983572,"version":"4.5.0"},"reference-count":138,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R56AI139658"],"award-info":[{"award-number":["R56AI139658"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00499","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:38:14Z","timestamp":1585010294000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":113,"title":["Targeting ADAM10 in Cancer and Autoimmunity"],"prefix":"10.3389","volume":"11","author":[{"suffix":"Jr.","given":"Timothy M.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Tharakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrm1548","article-title":"ADAMs: key components in EGFR signalling and development","volume":"6","author":"Blobel","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ceb.2003.08.001","article-title":"ADAMs: modulators of cell-cell and cell-matrix interactions","volume":"15","author":"White","year":"2003","journal-title":"Curr Opin Cell Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12135","DOI":"10.1074\/jbc.M114.624072","article-title":"The functional maturation of A Disintegrin and Metalloproteinase (ADAM) 9, 10, and 17 requires processing at a newly identified Proprotein Convertase (PC) cleavage site","volume":"290","author":"Wong","year":"2015","journal-title":"J Biol Chem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"35712","DOI":"10.1074\/jbc.M703231200","article-title":"The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events","volume":"282","author":"Moss","year":"2007","journal-title":"J Biol Chem"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.cell.2017.11.014","article-title":"Structural basis for regulated proteolysis by the alpha-secretase ADAM10","volume":"171","author":"Seegar","year":"2017","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1042\/BST20160296","article-title":"Regulation of the trafficking and the function of the metalloprotease ADAM10 by tetraspanins","volume":"45","author":"Saint-Pol","year":"2017","journal-title":"Biochem Soc Trans"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1547","DOI":"10.1038\/cddis.2014.492","article-title":"SAP97-mediated ADAM10 trafficking from golgi outposts depends on PKC phosphorylation","volume":"5","author":"Saraceno","year":"2014","journal-title":"Cell Death Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"37531","DOI":"10.1074\/jbc.M110.141556","article-title":"CD23 sheddase a disintegrin and metalloproteinase 10 (ADAM10) is also required for CD23 sorting into B cell-derived exosomes","volume":"285","author":"Mathews","year":"2010","journal-title":"J Biol Chem"},{"key":"B9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1074\/jbc.272.1.556","article-title":"Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene","volume":"272","author":"Kuno","year":"1997","journal-title":"J Biol Chem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0092-8674(00)80519-X","article-title":"Metalloprotease-disintegrins: links to cell adhesion and cleavage of TNF alpha and notch","volume":"90","author":"Blobel","year":"1997","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"13233","DOI":"10.1073\/pnas.93.23.13233","article-title":"The cell surface metalloprotease\/disintegrin kuzbanian is required for axonal extension in Drosophila","volume":"93","author":"Fambrough","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1006\/dbio.1996.8458","article-title":"ADAM 13: a novel ADAM expressed in somitic mesoderm and neural crest cells during Xenopus laevis development","volume":"182","author":"Alfandari","year":"1997","journal-title":"Dev Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1242\/dev.076398","article-title":"Ectodomain shedding and ADAMs in development","volume":"139","author":"Weber","year":"2012","journal-title":"Development"},{"key":"B14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.2174\/138161209788682442","article-title":"ADAM10 as a therapeutic target for cancer and inflammation","volume":"15","author":"Crawford","year":"2009","journal-title":"Curr Pharm Des"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.molimm.2010.12.005","article-title":"The emergence of ADAM10 as a regulator of lymphocyte development and autoimmunity","volume":"48","author":"Gibb","year":"2011","journal-title":"Mol Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1093\/hmg\/11.21.2615","article-title":"The disintegrin\/metalloprotease ADAM 10 is essential for notch signalling but not for alpha-secretase activity in fibroblasts","volume":"11","author":"Hartmann","year":"2002","journal-title":"Hum Mol Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1016\/j.yexcr.2009.07.029","article-title":"Ectodomain shedding of E-cadherin and c-Met is induced by Helicobacter pylori infection","volume":"315","author":"Schirrmeister","year":"2009","journal-title":"Exp Cell Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1091\/mbc.e08-11-1135","article-title":"ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha","volume":"20","author":"Le Gall","year":"2009","journal-title":"Mol Biol Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1083\/jcb.200307137","article-title":"Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands","volume":"164","author":"Sahin","year":"2004","journal-title":"J Cell Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1038\/sj.cdd.4402175","article-title":"The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells","volume":"14","author":"Kirkin","year":"2007","journal-title":"Cell Death Differ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"36083","DOI":"10.1074\/jbc.M113.506220","article-title":"CD154 is released from T-cells by a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) and ADAM17 in a CD40 protein-dependent manner","volume":"288","author":"Yacoub","year":"2013","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.4049\/jimmunol.1700833","article-title":"ADAM10-mediated ICOS ligand shedding on B Cells is necessary for proper T cell ICOS regulation and T follicular helper responses","volume":"199","author":"Lownik","year":"2017","journal-title":"J Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/ijc.28174","article-title":"Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the a disintegrin and metalloproteases 10 and 17","volume":"133","author":"Chitadze","year":"2013","journal-title":"Int J cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-05-2520","article-title":"Proteolytic release of soluble UL16-binding protein 2 from tumor cells","volume":"66","author":"Waldhauer","year":"2006","journal-title":"Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.canlet.2019.10.003","article-title":"ADAM proteases: emerging role and targeting of the non-catalytic domains","volume":"467","author":"Saha","year":"2019","journal-title":"Cancer Lett"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1007\/s00018-019-03173-7","article-title":"Functions of A disintegrin and metalloproteases (ADAMs) in the mammalian nervous system","volume":"76","author":"Hsia","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fcell.2018.00153","article-title":"Renal ADAM10 and 17: their physiological and medical meanings","volume":"6","author":"Kato","year":"2018","journal-title":"Front cell Dev Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev.immunol.021908.132719","article-title":"Functions of notch signaling in the immune system: consensus and controversies","volume":"28","author":"Yuan","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41577-018-0068-5","article-title":"The emerging role of ADAM metalloproteinases in immunity","volume":"18","author":"Lambrecht","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"31018","DOI":"10.1074\/jbc.M109.006775","article-title":"Metalloprotease ADAM10 is required for notch1 site 2 cleavage","volume":"284","author":"van Tetering","year":"2009","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.4049\/jimmunol.1003318","article-title":"ADAM10 overexpression shifts lympho- and myelopoiesis by dysregulating site 2\/site 3 cleavage products of notch","volume":"186","author":"Gibb","year":"2011","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1126\/scisignal.aag2989","article-title":"Ligand-activated notch undergoes DTX4-mediated ubiquitylation and bilateral endocytosis before ADAM10 processing","volume":"10","author":"Chastagner","year":"2017","journal-title":"Sci Signal"},{"key":"B34","doi-asserted-by":"publisher","first-page":"11738","DOI":"10.1074\/jbc.M805894200","article-title":"ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase","volume":"284","author":"Tousseyn","year":"2009","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1084\/jem.20091990","article-title":"ADAM10 is essential for notch2-dependent marginal zone B cell development and CD23 cleavage in vivo","volume":"207","author":"Gibb","year":"2010","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/ni1399","article-title":"ADAM10 is a principal sheddase of the low-affinity immunoglobulin E receptor CD23","volume":"7","author":"Weskamp","year":"2006","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/35006664","article-title":"The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate","volume":"404","author":"Yasutomo","year":"2000","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0092-8674(00)81929-7","article-title":"Notch activity influences the alphabeta versus gammadelta T cell lineage decision","volume":"88","author":"Washburn","year":"1997","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0092-8674(00)81368-9","article-title":"An activated form of notch influences the choice between CD4 and CD8 T cell lineages","volume":"87","author":"Robey","year":"1996","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/ni.2538","article-title":"Distinct TCR signaling pathways drive proliferation and cytokine production in T cells","volume":"14","author":"Guy","year":"2013","journal-title":"Nat Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nm.3758","article-title":"Notch controls the survival of memory CD4+ T cells by regulating glucose uptake","volume":"21","author":"Maekawa","year":"2015","journal-title":"Nat Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fimmu.2012.00023","article-title":"Regulation of antigen-experienced T cells: lessons from the quintessential memory marker CD44","volume":"3","author":"Baaten","year":"2012","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1349-7006.2004.tb03179.x","article-title":"Mechanism and biological significance of CD44 cleavage","volume":"95","author":"Nagano","year":"2004","journal-title":"Cancer Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.molimm.2015.02.008","article-title":"Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes","volume":"65","author":"Ebsen","year":"2015","journal-title":"Mol Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1158\/0008-5472.CAN-11-1620","article-title":"Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape","volume":"72","author":"Woo","year":"2012","journal-title":"Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nature24014","article-title":"Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma","volume":"549","author":"Venkatesh","year":"2017","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1002\/cam4.1538","article-title":"Glioblastoma recurrence correlates with NLGN3 levels","volume":"7","author":"Liu","year":"2018","journal-title":"Cancer Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00441-015-2197-5","article-title":"Characterization of matrix metalloproteinase-2 and\u22129, ADAM-10 and N-cadherin expression in human glioblastoma multiforme","volume":"362","author":"Musumeci","year":"2015","journal-title":"Cell Tissue Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1523\/JNEUROSCI.5126-08.2009","article-title":"ADAM-10-mediated N-Cadherin cleavage is protein kinase C-alpha dependent and promotes glioblastoma cell migration","volume":"29","author":"Kohutek","year":"2009"},{"key":"B50","first-page":"618","article-title":"High expression of ADAM10 predicts a poor prognosis for patients with glioblastoma","volume":"10","author":"Kanaya","year":"2017"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/jcm8101526","article-title":"NT5E\/CD73 as correlative factor of patient survival and natural killer cell infiltration in glioblastoma","volume":"8","author":"Wang","year":"2019","journal-title":"J Clin Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e30881","DOI":"10.7554\/eLife.30881","article-title":"Endothelial cells express NKG2D ligands and desensitize antitumor NK responses","volume":"6","author":"Thompson","year":"2017","journal-title":"Elife"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.3892\/mmr.2019.10583","article-title":"Upregulation of Myc promotes the evasion of NK cellmediated immunity through suppression of NKG2D ligands in K562 cells","volume":"20","author":"Lee","year":"2019","journal-title":"Mol Med Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"8050","DOI":"10.1158\/0008-5472.CAN-09-0789","article-title":"Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma","volume":"69","author":"Kohga","year":"2009","journal-title":"Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/neuonc\/not232","article-title":"A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells","volume":"16","author":"Wolpert","year":"2013","journal-title":"Neuro Oncol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"BSR20182361","DOI":"10.1042\/BSR20182361","article-title":"Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia\/macrophage polarization state with metalloprotease expression profiles and survival","volume":"39","author":"Gjorgjevski","year":"2019","journal-title":"Biosci Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1023\/A:1023047431869","article-title":"Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials","volume":"22","author":"Pavlaki","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"B58","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1073\/pnas.96.7.3922","article-title":"Constitutive and regulated \u03b1-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease","volume":"96","author":"Lammich","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1038\/emboj.2010.167","article-title":"ADAM10 is the physiologically relevant, constitutive \u03b1-secretase of the amyloid precursor protein in primary neurons","volume":"29","author":"Kuhn","year":"2010","journal-title":"EMBO J"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/HS9.0000000000000020","article-title":"Immune checkpoint inhibition in hodgkin lymphoma","volume":"2","author":"Moy","year":"2018","journal-title":"HemaSphere"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/bjc.2017.79","article-title":"MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue","volume":"116","author":"Ghadially","year":"2017","journal-title":"Br J Cancer"},{"key":"B62","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1080\/15384047.2016.1177684","article-title":"The ADAMs family of proteases as targets for the treatment of cancer","volume":"17","author":"Mullooly","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e1123367","DOI":"10.1080\/2162402X.2015.1123367","article-title":"ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing hodgkin lymphoma cells to NKG2D-mediated killing","volume":"5","author":"Zocchi","year":"2015","journal-title":"Oncoimmunology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e1421889","DOI":"10.1080\/2162402X.2017.1421889","article-title":"Specific ADAM10 inhibitors localize in exosome-like vesicles released by hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells","volume":"7","author":"Tosetti","year":"2018","journal-title":"Oncoimmunology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"30523","DOI":"10.18632\/oncotarget.8864","article-title":"CD30 on extracellular vesicles from malignant hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with brentuximab-Vedotin, in vitro","volume":"7","author":"Hansen","year":"2016","journal-title":"Oncotarget"},{"key":"B66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ab.2019.06.001","article-title":"Application of high-mannose-type glycan-specific lectin from oscillatoria agardhii for affinity isolation of tumor-derived extracellular vesicles","volume":"580","author":"Yamamoto","year":"2019","journal-title":"Anal Biochem"},{"key":"B67","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1586\/14737140.2015.1023712","article-title":"New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy","volume":"15","author":"Chihara","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"B68","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1182\/blood-2019-124189","article-title":"Tumor ADAM10\/ADAM17-Mediated PD-L1 loss may predict poor outcomes in diffuse large B cell lymphoma","volume":"134","author":"Orme","year":"2019","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00262-019-02437-2","article-title":"Proteolytic processing of PD-L1 by ADAM proteases in breast cancer cells","volume":"69","author":"Romero","year":"2019","journal-title":"Cancer Immunol Immunother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1182\/asheducation-2017.1.194","article-title":"Shall we treat smoldering multiple myeloma in the near future?","volume":"2017","author":"Landgren","year":"2017","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"B71","doi-asserted-by":"publisher","first-page":"736","DOI":"10.4049\/jimmunol.1402643","article-title":"Genotoxic stress induces senescence-associated ADAM10-dependent release of NKG2D MIC ligands in multiple myeloma cells","volume":"195","author":"Zingoni","year":"2015","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10585-018-9929-3","article-title":"Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment","volume":"35","author":"Baker","year":"2018","journal-title":"Clin Exp Metastasis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-016-0302-1","article-title":"A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the warburg effect via activation of the PI3K\/AKT signaling pathway","volume":"9","author":"Liu","year":"2016","journal-title":"J Hematol Oncol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/cam4.1859","article-title":"Elevated serum HER-2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression","volume":"8","author":"Zheng","year":"2019","journal-title":"Cancer Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"6633","DOI":"10.18632\/oncotarget.1955","article-title":"ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer","volume":"5","author":"Feldinger","year":"2014","journal-title":"Oncotarget"},{"key":"B76","doi-asserted-by":"publisher","first-page":"10243","DOI":"10.18632\/oncotarget.7200","article-title":"ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3","volume":"7","author":"Ebbing","year":"2016","journal-title":"Oncotarget"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1634\/theoncologist.2016-0067","article-title":"Biology and management of patients with triple-negative breast cancer","volume":"21","author":"Sharma","year":"2016","journal-title":"Oncologist"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1200\/jco.2011.29.15_suppl.1062","article-title":"ADAMs as new therapeutic targets for triple-negative breast cancer","volume":"29","author":"Mullooly","year":"2011","journal-title":"J Clin Oncol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/bjc.2015.288","article-title":"ADAM10: a new player in breast cancer progression?","volume":"113","author":"Mullooly","year":"2015","journal-title":"Br J Cancer"},{"key":"B80","first-page":"1905","article-title":"miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10","volume":"24","author":"Liu","year":"2019","journal-title":"J BUON"},{"key":"B81","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ebiom.2018.11.012","article-title":"Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer","volume":"38","author":"Tsang","year":"2018","journal-title":"EBioMed"},{"key":"B82","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JAD-170061","article-title":"The role of ADAM10 in Alzheimer's disease","volume":"58","author":"Yuan","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"B83","doi-asserted-by":"publisher","first-page":"108661","DOI":"10.1016\/j.biopha.2019.108661","article-title":"ADAM10 in Alzheimer's disease: pharmacological modulation by natural compounds and its role as a peripheral marker","volume":"113","author":"Manzine","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1002\/jcp.26097","article-title":"The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands","volume":"233","author":"Urriola-Mu\u00f1oz","year":"2018","journal-title":"J Cell Physiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12943-019-0983-5","article-title":"Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review","volume":"18","author":"Peltanova","year":"2019","journal-title":"Mol Cancer"},{"key":"B86","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5114\/pjp.2018.75339","article-title":"Overexpression of ADAM10 in oral squamous cell carcinoma with metastases","volume":"69","author":"Stasikowska-Kanicka","year":"2018","journal-title":"Pol J Pathol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41419-019-2016-0","article-title":"Loss of TIMP3 by promoter methylation of Sp1 binding site promotes oral cancer metastasis","volume":"10","author":"Su","year":"2019","journal-title":"Cell Death Dis"},{"key":"B88","doi-asserted-by":"publisher","first-page":"14697","DOI":"10.1038\/s41598-018-32910-4","article-title":"Increased TIMP-3 expression alters the cellular secretome through dual inhibition of the metalloprotease ADAM10 and ligand-binding of the LRP-1 receptor","volume":"8","author":"Scilabra","year":"2018","journal-title":"Sci Rep"},{"key":"B89","first-page":"18208","article-title":"Expression of MICA in oral squamous carcinoma cells and its effect on NK cells","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1111\/cas.14143","article-title":"A novel pan-cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic","volume":"110","author":"Liu","year":"2019","journal-title":"Cancer Sci"},{"key":"B91","doi-asserted-by":"publisher","first-page":"5035234","DOI":"10.1155\/2019\/5035234","article-title":"Adamalysines as biomarkers and a potential target of therapy in colorectal cancer patients: preliminary results","volume":"2019","author":"Walkiewicz","year":"2019","journal-title":"Dis Markers"},{"key":"B92","first-page":"309","article-title":"ADAM10 is a potential novel prognostic biomarker for sacral chordoma","volume":"49","author":"Ding","year":"2019","journal-title":"Ann Clin Lab Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"Mcinnes","year":"2011"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/art.21004","article-title":"Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints","volume":"52","author":"Voort R Van","year":"2005"},{"key":"B95","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/art.37755","article-title":"ADAM-10 is overexpressed in rheumatoid arthritis synovial tissue and mediates angiogenesis","volume":"65","author":"Isozaki","year":"2013"},{"key":"B96","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.trsl.2015.02.005","article-title":"A disintegrin and metalloprotease-10 is correlated with disease activity and mediates monocyte migration and adhesion in rheumatoid arthritis","volume":"166","author":"Isozaki","year":"2015","journal-title":"Transl Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.3892\/mmr.2015.4011","article-title":"Knockdown of ADAM10 inhibits migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis","author":"Li","year":"2015"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Targeted treatments for rheumatoid arthritis 1 pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"Mcinnes","year":"2017","journal-title":"Lancet"},{"key":"B99","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/jor.22492","article-title":"Lack of ADAM10 in endothelial cells affects osteoclasts at the chondro-osseus junction","author":"Zhao","year":"2014"},{"key":"B100","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1080\/14397595.2016.1256025","article-title":"A disintegrin and metalloproteinase (ADAM)-10 as a predictive factor for tocilizumab effectiveness in rheumatoid arthritis","volume":"27","author":"Isozaki","year":"2017","journal-title":"Mod Rheumatol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13075-018-1657-1","article-title":"ADAM-17 is expressed on rheumatoid arthritis fibroblast-like synoviocytes and regulates proinflammatory mediator expression and monocyte adhesion","volume":"20","author":"Ishii","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B102","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.bbrc.2015.04.111","article-title":"Anti-arthritis effect of a novel quinazoline derivative through inhibiting production of TNF-\u03b1 mediated by TNF-\u03b1 converting enzyme in murine collagen-induced arthritis model","volume":"462","author":"Pu","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/rheumatology\/kew237","article-title":"A disintegrin and metalloprotease-17 and galectin-9 are important regulators of local 4-1BB activity and disease outcome in rheumatoid arthritis","volume":"55","author":"Nielsen","year":"2016","journal-title":"Rheumatol (oxford)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"L325","DOI":"10.1152\/ajplung.00294.2014","article-title":"Adam-family metalloproteinases in lung inflammation: potential therapeutic targets","volume":"308","author":"Dreymueller","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1158\/1078-0432.CCR-06-2116","article-title":"Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer","volume":"13","author":"Fridman","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B106","doi-asserted-by":"publisher","first-page":"102356","DOI":"10.1016\/j.jaut.2019.102356","article-title":"Evolving story of autoantibodies in systemic lupus erythematosus","author":"Pisetsky","year":"2019","journal-title":"J Autoimmun"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1002\/art.23678","article-title":"Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus","volume":"58","author":"Petri","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J Exp Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"MacKay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"542","DOI":"10.4049\/jimmunol.1402070","article-title":"The immunoregulator soluble TACI is released by ADAM10 and reflects B-cell activation in autoimmunity","volume":"194","author":"Hoffmann","year":"2015","journal-title":"J Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"L325","DOI":"10.4049\/jimmunol.1801207","article-title":"B cell ADAM10 controls murine lupus progression through regulation of the ICOS:ICOS ligand axis","volume":"308","author":"Lownik","year":"2019","journal-title":"J Immunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1084\/jem.20051725","article-title":"Twist mediates suppression of inflammation by type I IFNs and Axl","volume":"203","author":"Sharif","year":"2006","journal-title":"J Exp Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clim.2016.05.011","article-title":"Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE","volume":"169","author":"Orme","year":"2016","journal-title":"Clin Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/jcb.20216","article-title":"Taming psoriatic keratinocytes - PTHs' uses go up another notch","volume":"93","author":"Whitfield","year":"2004","journal-title":"J Cell Biochem"},{"key":"B116","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/sj.cdd.4401036","article-title":"Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-\u03baB and PPAR\u03b3","volume":"9","author":"Nickoloff","year":"2002","journal-title":"Cell Death Differ"},{"key":"B117","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1242\/dev.055210","article-title":"The disintegrin\/metalloproteinase Adam10 is essential for epidermal integrity and notch-mediated signaling","volume":"138","author":"Weber","year":"2011","journal-title":"Development"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1111\/j.1365-2133.2008.08513.x","article-title":"Reichrath J. Overexpression of ADAM 10 and ADAM 12 in lesional psoriatic skin","volume":"158","author":"Oh","year":"2008"},{"key":"B119","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1517\/17425255.4.7.953","article-title":"An updated review of acitretin\u2013a systemic retinoid for the treatment of psoriasis","volume":"4","author":"Pang","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1096\/fj.08-121392","article-title":"Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin","volume":"23","author":"Tippmann","year":"2019","journal-title":"FASEB J."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/jnr.23421","article-title":"Cilostazol suppresses \u03b2-amyloid production by activating a disintegrin and metalloproteinase 10 via the upregulation of SIRT1-coupled retinoic acid receptor-\u03b2","volume":"92","author":"Lee","year":"2014","journal-title":"J Neurosci Res"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1248\/bpb.b12-00314","article-title":"Tamibarotene: a candidate retinoid drug for Alzheimer's disease","volume":"35","author":"Fukasawa","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"B123","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.bbamcr.2017.06.005","article-title":"The metalloproteinase ADAM10: a useful therapeutic target?","volume":"1864","author":"Wetzel","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1471-4159.2008.05396.x","article-title":"Etazolate, a neuroprotective drug linking GABAA receptor pharmacology to amyloid precursor protein processing","volume":"106","author":"Marcade","year":"2008","journal-title":"J Neurochem"},{"key":"B125","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1111\/jcmm.14457","article-title":"Bryostatin-1 ameliorated experimental colitis in Il-10\u2212\/\u2212 mice by protecting the intestinal barrier and limiting immune dysfunction","volume":"23","author":"Zuo","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3892\/mmr.2017.7993","article-title":"Bryostatin 1 causes attenuation of TPA-mediated tumor promotion in mouse skin","volume":"17","author":"Zeng","year":"2018","journal-title":"Mol Med Rep"},{"key":"B127","doi-asserted-by":"publisher","first-page":"16419","DOI":"10.1074\/jbc.M600617200","article-title":"ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate- induced alpha-secretase cleavage of amyloid precursor protein","volume":"281","author":"Obregon","year":"2006","journal-title":"J Biol Chem"},{"key":"B128","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.clnu.2019.02.028","article-title":"A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with fragile X syndrome","volume":"39","author":"de la Torre","year":"2019","journal-title":"Clin Nutr"},{"key":"B129","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/1940-6207.CAPR-18-0147","article-title":"Prodiet: a phase II randomized placebo-controlled trial of green tea catechins and lycopene in men at increased risk of prostate cancer","volume":"11","author":"Athene Lane","year":"2018","journal-title":"Cancer Prev Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jdermsci.2013.12.001","article-title":"Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII","volume":"73","author":"Nishie","year":"2014","journal-title":"J Dermatol Sci"},{"key":"B131","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1038\/jid.2013.236","article-title":"Association of serum b-cell activating factor level and proportion of memory and transitional b cells with clinical response after rituximab treatment of bullous pemphigoid patients","volume":"133","author":"Hall","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jid.2017.09.037","article-title":"Semaphorin 4D from CD15 + granulocytes via ADAM10-induced cleavage contributes to antibody production in bullous pemphigoid","volume":"138","author":"Shen","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1749-6632.1999.tb07688.x","article-title":"Preclinical and clinical studies of MMP inhibitors in cancer","volume":"878","author":"Drummond","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"B134","first-page":"513","article-title":"Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions","volume":"5","author":"Macaulay","year":"1999","journal-title":"Clin cancer Res"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1084\/jem.20151095","article-title":"An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth","volume":"213","author":"Atapattu","year":"2016","journal-title":"J Exp Med"},{"key":"B136","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000345983","article-title":"ADAM10 as a biomarker for Alzheimer's disease: a study with Brazilian elderly","volume":"35","author":"Manzine","year":"2013","journal-title":"Dement Geriatr Cogn Disord"},{"key":"B137","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12974-018-1255-9","article-title":"Levels of ADAM10 are reduced in Alzheimer's disease CSF","volume":"15","author":"Sogorb-Esteve","year":"2018","journal-title":"J Neuroinflammation"},{"key":"B138","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1423-0127-17-3","article-title":"ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases","volume":"17","author":"Gutwein","year":"2010","journal-title":"J Biomed Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00499\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:38:18Z","timestamp":1585010298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00499\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":138,"alternative-id":["10.3389\/fimmu.2020.00499"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00499","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]},"article-number":"499"}}